Integration of proteomic and metabolomic characterization in atrial fibrillation-induced heart failure
Abstract Background The exact mechanism of atrial fibrillation (AF)-induced heart failure (HF) remains unclear. Proteomics and metabolomics were integrated to in this study, as to describe AF patients’ dysregulated proteins and metabolites, comparing patients without HF to patients with HF. Methods...
Main Authors: | Haiyu Zhang, Lu Wang, Dechun Yin, Qi Zhou, Lin Lv, Zengxiang Dong, Yuanqi Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-12-01
|
Series: | BMC Genomics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12864-022-09044-z |
Similar Items
-
Metabolomic Profiles, Ideal Cardiovascular Health, and Risk of Heart Failure and Atrial Fibrillation: Insights From the Framingham Heart Study
by: Yi Li, et al.
Published: (2023-06-01) -
Multiple targets related to mitochondrial function unveiled by metabolomics and proteomics profiles of hearts from atrial fibrillation patients
by: Weizhuo Liu, et al.
Published: (2023-04-01) -
Atrial Fibrillation and Heart Failure
by: Leonard Bergau, et al.
Published: (2022-04-01) -
Atrial Fibrillation Ablation in Heart Failure Patients
by: Michael Derndorfer, et al.
Published: (2021-08-01) -
The impact of myocardial fibrosis biomarkers in a heart failure population with atrial fibrillation—The HARVEST-Malmö study
by: Zainu Nezami, et al.
Published: (2022-10-01)